These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 25054405

  • 1. Androgen deficiency in long-term intrathecal opioid administration.
    Kim CH, Garcia R, Stover J, Ritchie K, Whealton T, Ata MA.
    Pain Physician; 2014; 17(4):E543-8. PubMed ID: 25054405
    [Abstract] [Full Text] [Related]

  • 2. Endocrine consequences of long-term intrathecal administration of opioids.
    Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
    [Abstract] [Full Text] [Related]

  • 3. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
    Daniell HW.
    J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
    [Abstract] [Full Text] [Related]

  • 4. Elucidating risk factors for androgen deficiency associated with daily opioid use.
    Rubinstein A, Carpenter DM.
    Am J Med; 2014 Dec; 127(12):1195-201. PubMed ID: 25063648
    [Abstract] [Full Text] [Related]

  • 5. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).
    Ajo R, Segura A, Mira L, Inda MD, Alfayate R, Sánchez-Barbie A, Margarit C, Peiró AM.
    Aging Male; 2017 Mar; 20(1):1-8. PubMed ID: 27750480
    [Abstract] [Full Text] [Related]

  • 6. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS, Harned ME, Etscheidt MA.
    Pain Physician; 2011 Mar; 14(4):343-51. PubMed ID: 21785477
    [Abstract] [Full Text] [Related]

  • 7. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
    Veizi IE, Hayek SM, Narouze S, Pope JE, Mekhail N.
    Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
    [Abstract] [Full Text] [Related]

  • 8. Opioid-induced androgen deficiency (OPIAD).
    Smith HS, Elliott JA.
    Pain Physician; 2012 Jul; 15(3 Suppl):ES145-56. PubMed ID: 22786453
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.
    Duarte RV, Raphael JH, Labib M, Southall JL, Ashford RL.
    Pain Physician; 2013 Jan; 16(1):9-14. PubMed ID: 23340538
    [Abstract] [Full Text] [Related]

  • 10. Association Between Commonly Prescribed Opioids and Androgen Deficiency in Men: A Retrospective Cohort Analysis.
    Rubinstein AL, Carpenter DM.
    Pain Med; 2017 Apr 01; 18(4):637-644. PubMed ID: 27516365
    [Abstract] [Full Text] [Related]

  • 11. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL, Carpenter DM, Minkoff JR.
    Clin J Pain; 2013 Oct 01; 29(10):840-5. PubMed ID: 24384986
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
    Hamza M, Doleys D, Wells M, Weisbein J, Hoff J, Martin M, Soteropoulos C, Barreto J, Deschner S, Ketchum J.
    Pain Med; 2012 Oct 01; 13(10):1304-13. PubMed ID: 22845187
    [Abstract] [Full Text] [Related]

  • 13. Outcome of intrathecal opioids in chronic non-cancer pain.
    Roberts LJ, Finch PM, Goucke CR, Price LM.
    Eur J Pain; 2001 Oct 01; 5(4):353-61. PubMed ID: 11743701
    [Abstract] [Full Text] [Related]

  • 14. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
    Du Pen S, Du Pen A, Hillyer J.
    Pain Med; 2006 Oct 01; 7(1):10-5. PubMed ID: 16533191
    [Abstract] [Full Text] [Related]

  • 15. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
    Jackson TP, Lonergan DF, Todd RD, Martin PR.
    Pain Pract; 2013 Apr 01; 13(4):297-309. PubMed ID: 22925591
    [Abstract] [Full Text] [Related]

  • 16. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW, Lentz R, Mazer NA.
    J Pain; 2006 Mar 01; 7(3):200-10. PubMed ID: 16516826
    [Abstract] [Full Text] [Related]

  • 17. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
    Zin CS, Nissen LM, O'Callaghan JP, Moore BJ, Smith MT.
    Pain Med; 2010 Apr 01; 11(4):550-61. PubMed ID: 20202139
    [Abstract] [Full Text] [Related]

  • 18. Long-term use of intrathecal droperidol as an excellent antiemetic in nonmalignant pain--a retrospective study.
    Ahmad-Sabry MH, Shareghi G.
    Middle East J Anaesthesiol; 2012 Oct 01; 21(6):857-62. PubMed ID: 23634568
    [Abstract] [Full Text] [Related]

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Oct 01; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 20. [Correlation between intrathecal opioids and gynecomastia -- a case report].
    Hosbach I, Zenz M.
    Schmerz; 2003 Jan 01; 17(1):60-2. PubMed ID: 12579390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.